Sector News

Pfizer to shut 55-year-old Mumbai manufacturing plant

July 15, 2015
Life sciences
Pfizer Ltd, the Indian unit of global pharmaceutical major Pfizer Inc., has decided to shut its manufacturing facility at Thane, near Mumbai, with effect from 16 September, the company said on Wednesday.
 
There has been no production activity at the plant since 2013, and the closure will not impact the supply of any of its medicines, according to company.
 
The decision to close the site is based on an assessment of its long-term viability and its ability to achieve the needed production, the statement said.
 
This Thane plant was commissioned in the 1960s. Pfizer had offered voluntary retirement scheme (VRS) to the workmen at the plant last year, which was taken up by as many as 132 of the 212 workmen, the company said.
 
The remaining 80 workmen continue to receive full wages, despite plant inactivity. As part of the closure process, the company will honour its obligations towards requisite compensation, as mandated by law, for the remaining workmen, it said.
 
Source: Live Mint

comments closed

Related News

October 2, 2022

GSK names Julie Brown, a 25-year AstraZeneca veteran, its first woman CFO

Life sciences

Five years ago, GSK made headlines when it hired Emma Walmsley to become the first woman to run a major pharmaceutical company. Now the Big Pharma has brought in another woman to control the company’s finances. Julie Brown will be GSK’s next chief financial officer. Brown, currently the chief operating and financial officer at fashion and beauty brand Burberry Group, is set to replace Iain Mackay.

October 2, 2022

Moderna creates new launch preparation role, poaches Novartis exec as manufacturing lead

Life sciences

Moderna created a new role responsible for “building out the company’s organization to support its growing pipeline.” Starting first thing 2023, Juan Andres, Moderna’s manufacturing head, will step into this new role under the title president of strategic partnerships and enterprise expansion, the company said Thursday.

October 2, 2022

Torrent Pharma to acquire Curatio for $245.16m

Life sciences

The latest takeover is anticipated to boost the presence of Torrent in the dermatology segment. Indian company Torrent Pharmaceuticals has signed a definitive agreement for the complete acquisition of Curatio Healthcare for $245.16m (Rs20bn).